epirubicin
information and resources from the National Cancer Institute
Ellence
A component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer.
Pharmacia & Upjohn Company Sep 15 1999
|
|
|
|
news articles
Arsenic Trioxide Effective as Single Agent in Newly Diagnosed APL Mar 31, 2006
Cancer Consultants (press release), Standard initial treatment for APL consists of chemotherapy, including an anthracycline (doxorubicin, epirubicin, mitoxantrone, idarubicin) and the agent all ...
Sanofi-Aventis: Taxotere fighting to maintain blockbuster status Mar 29, 2006
Pharmaceutical Business Review The current standard treatment consisting of epirubicin in combination with cisplatin and 5-FU offers a median overall survival of 8.9 months. ...
Former Texas Gov. Ann Richards has esophagus cancer Mar 9, 2006
Food Consumer, In more recent studies, addition of epirubicin (ECF) was better than other comparable regimens in advanced nonresectable cancer (Ross et al 2002). ...
Callisto Pharma Expands Research Trial Of Cancer Drug L-Annamycin ... Mar 21, 2006
Trading Markets, ...drugs in clinical use today. Compounds in this class include doxorubicin, daunorubicin and epirubicin. These drugs are all close ...
Interlocutory Injunctions for Pharmaceutical Patent Infringement Mar 15, 2006
Mondaq News Alerts, Under that licence, Pfizer manufactures and sells ready-to-use solutions of doxorubicin hydrochloride and epirubicin hydrochloride. ...
Addition of Ellence® to Standard Chemotherapy Does Not Improve ... Mar 2, 2006
Cancer Consultants (press release), According to an article recently published in the Journal of Clinical Oncology, the addition of the chemotherapy agent Ellence® (epirubicin) to the standard ...
(PZ) VioQuest Pharmaceuticals Appoints an Industry Veteran as ... Mar 15, 2006
Houston Chronicle, ...director for Pfizer, where she was responsible for US development of Aromasin, an aromatase inhibitor for breast cancer, and Epirubicin, an anthracycline for ...
Genepharm's First Cancer Drugs Approved By TGA, Australia Mar 11, 2006
Medical News Today (press release), The approved drugs, Epirubicin and Carboplatin, are two of the leading drugs used in Australian hospitals for the treatment of cancer. ...
Adjuvant High-Dose Chemotherapy Improves Outcomes of HER2/neu ... Mar 7, 2006
Cancer Consultants (press release), ...receiving high-dose chemotherapy with Cytoxan® (cyclophosphamide), Thiplex® (thiotepa), and Platinol® following FEC (5-FU, epirubicin, and cyclophosphamide ...
Adjuvant Taxotere® and Herceptin® Effective for Breast Cancer ... Mar 6, 2006
Cancer Consultants (press release), FinHer Study have reported that Taxotere® (docetaxel) is superior to Navelbine® (vinorelbine) when given in addition to 5-FU, epirubicin and cyclophosphamide ...
High-Dose Chemotherapy Improves Outcomes of HER2/neu Negative ... Mar 13, 2006
Cancer Consultants (press release), ...cancer). They were treated with a standard chemotherapy regimen referred to as FEC (5-fluorouracil, epirubicin, cyclophosphamide). ...
Breast Cancer Treatment Dec 16, 2005
Food Consumer, 154. Levine MN, Bramwell VH, Pritchard KI, et al.: Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with ...
Short Course of Herceptin® in Patients with Breast Cancer Dec 9, 2005
Cancer Consultants (press release), In breast cancer patients treated with docetaxel or vinorelbine followed by FEC (5-fluorouracil, epirubicin, cyclophosphamide), a nine-week course of Herceptin ...
Taxol reduces breast cancer recurrence Dec 15, 2005
myDNA.com, The research team used conventional treatment methods as the control method, administering six cycles of fluorouracil (5FU), Ellence (epirubicin) and Cytoxan ...
High-dose Chemotherapy Plus Growth Factor Helps in Locally ... Dec 2, 2005
MedPage Today, The high-dose regimen (201 patients) consisted of two cycles of epirubicin and cyclophosphamide followed by tandem epirubicin and cyclophosphamide plus ...
Dose-dense Chemotherapy For Early Breast Cancer Found Safe ... Dec 7, 2005
Science Daily (press release) A total of 1214 women with early-stage breast cancer were randomly assigned to receive six courses of 5-fluorouracil, epirubicin, and cyclophosphamide (FEC ...
Benefit of Dose-Dense Chemotherapy for Early Breast Cancer Still ... Dec 7, 2005
Cancer Consultants (press release), Women were randomly assigned to receive 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) every three weeks or every two weeks, for a total of six cycles. ...
Tandem High-Dose Chemotherapy Superior to Dose-Dense Chemotherapy ... Dec 5, 2005
Cancer Consultants (press release), All patients received 2 courses of chemotherapy with epirubicin and cyclophosphamide (EC) at 2 week intervals supported by Neupogen. ...
Long-Term Safety of Dose-Dense Adjuvant Chemotherapy for Breast ... Dec 8, 2005
Cancer Consultants (press release), ...with the Gruppo Oncologico Nord Ovest-Mammella Inter Gruppo (GONO-MIG) has reported that a dose-dense regimen of fluorouracil, epirubicin, and cyclophosphamide ...
Treatment of Breast Cancer with Herceptin for Nine Weeks Dec 10, 2005
MedIndia, The women included in the study received docetaxel or vinorelbine and then FEC (5-fluorouracil, epirubicin, cyclophosphamide).Those whose HER-2 protein were ...
SABCS: Shorter Chemotherapy Regimen Plus Taxol Reduces Breast ... Dec 12, 2005
MedPage Today, ...control arm of the study, started in the late 1990s, used a regimen commonly used in Europe -- six cycles of 5-fluorouracil, Ellence (epirubicin), and Cytoxan ...
|
|
